Skip to main content

Table 3 Postoperative outcomes

From: Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures

Characteristic Arista® AH (n = 103) Control (n = 137) p-value
CT output 48 hrs postop (mL) 1594 ± 949 2112 ± 1437 <0.001
PRBCs 48 hrs postop (units) 2.4 ± 2.5 4.0 ± 5.1 <0.001
-Patients received 1–2 units 35 (34%) 56 (41%) --
-Patients received ≥3 units 34 (33%) 49 (36%) --
ICU platelets 48 hrs postop (units) 1.2 ± 2.3 1.8 ± 3.4 0.10
ICU FFP 48 hrs postop (units) 1.2 ± 2.6 1.9 ± 3.7 0.12
ICU stay (median days) 8(range 2–37) 9(range 2–57) 0.08
30 day mortality, (%) 17.5% 16.1% NS
  1. CT= chest tube; PRBC= Packed red blood cells; CPB= cardiopulmonary bypass; EBL= estimated blood loss; FFP= fresh frozen plasma; ICU= intensive care unit.